MAPK3 and head and neck squamous cell carcinoma: Consistent with these findings, knocking down SPHK1 in SAS and SCC15 HNSCC cells inhibited ERK1/2 kinase activation but had no significant effect on JNK and p38 kinase activation (Figure 4F).